“The ratings reflect our view of such factors as UCHealth’s significant market presence, excellent historical profitability and cash flow resulting in solid pro forma maximum annual debt service coverage and operational liquidity that provides significant cushion,” said S&P analyst Brian Williamson.
The ratings agency also affirmed the ratings on UCHA’s following bonds:
- “AA-” long-term rating on its series 2012A bonds
- “AA-” long-term rating on its series 2012B bonds
- “AA-” long-term rating on its series 2017A bonds
- “AA-” long-term rating on its series 2017C-1 bonds
- “AA-” long-term rating on its series 2017C-2 bonds
S&P also affirmed the “AA-” rating on UCHA’s series 2005A, 2005B and 2005C bonds issued for Fort Collins, Colo.-based Poudre Valley Health System.
The outlook is stable, reflecting S&P’s expectation UCHA’s financial results will most likely remain strong and its balance sheet metrics will improve.
More articles on healthcare finance:
Moody’s revises St. John Health System’s outlook to negative
Moody’s downgrades Capital Region Medical Center’s rating to ‘Baa1’
Moody’s revises Tampa Bay General Hospital’s outlook to stable
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
